Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Updated Guidance on Juvenile Idiopathic Arthritis Management
November 2025
The new systemic juvenile idiopathic arthritis recommendations outline evidence-based treatment strategies that prioritize early pathway inhibition and careful glucocorticoid use.
Read more
9 Jul 2025
Routine Biopsy May Be Key to Catching Lupus Nephritis Early
Lupus nephritis recurrence after kidney transplant may occur silently and more frequently than previously recognized, according to a new multisite retrospective study using both surveillance and indication biopsies.
7 Jul 2025
Rheumatoid Arthritis Therapy Hinges on Infection Check
Screening for latent tuberculosis (TB), hepatitis C virus (HCV), and occult hepatitis B virus (HBV) is critical before initiating biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) in patients with rheumatoid arthritis (RA), according to a recent clinical audit conducted in Pakistan.
4 Jul 2025
Mixed Rhinitis May Be Overlooked in Youth
A new study suggests that mixed rhinitis (MR) may be a significantly underrecognized condition in children and adolescents previously diagnosed with allergic rhinitis (AR), with nearly half of patients potentially misclassified.
2 Jul 2025
Stem Cell Strategies Show Promise in Systemic Sclerosis
Stem cell–based therapies may offer a transformative approach for systemic sclerosis, according to a new review that evaluates both current limitations and emerging solutions in regenerative treatment.
30 Jun 2025
Uncovering Pediatric Behçet’s Disease Clusters
New research provides critical insights into the phenotypic clusters of pediatric Behçet’s disease, highlighting the complexity and variability of clinical presentations in children with this rare inflammatory condition.
27 Jun 2025
Men Face Greater Organ Damage in Lupus
SEX significantly influences the onset, severity, and progression of systemic lupus erythematosus (SLE), according to a new scoping review that synthesizes data from nearly a decade of clinical research.
26 Jun 2025
Study Flags Autoimmune Concerns with GLP-1 Use
Patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S. cohort.
25 Jun 2025
Common Osteoarthritis Genes Not Linked to Progression
Genetic risk scores for knee osteoarthritis do not predict disease progression, new cohort study reveals.
Loading posts...
« Previous
1
…
6
7
8
9
10
…
20
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View